| Cas No.: | 2126819-40-5 |
| Chemical Name: | 3-Benzyl-9-methyl-2-((1-methyl-1H-pyrazol-4-yl)ethynyl)-4H,6Hthieno[2,3-e][1,2,4]triazolo[3,4-c][1,4]oxazepine |
| Synonyms: | QCA 276;QCA-276 |
| SMILES: | O1CC2C(CC3=CC=CC=C3)=C(C#CC3=CN(C)N=C3)SC=2N2C(C)=NN=C2C1 |
| Formula: | C22H19N5Os |
| M.Wt: | 401.488 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | QCA276 is a novel potent BET proteins inhibitor with IC50/Ki of 10/.3 nM, QCA276 is the BET ligand for PROTAC QCA570; effectively inhibits human BRD2, BRD3, and BRD4 BD1 and BD2 proteins with Ki of 2-20 nM. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
